HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Janet A Sawicki Selected Research

Spermine

2/2002Targeted expression of spermidine/spermine N1-acetyltransferase increases susceptibility to chemically induced skin carcinogenesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Janet A Sawicki Research Topics

Disease

16Neoplasms (Cancer)
04/2016 - 02/2002
5Adenocarcinoma
01/2016 - 10/2008
4Ovarian Neoplasms (Ovarian Cancer)
04/2016 - 03/2009
4Pancreatic Neoplasms (Pancreatic Cancer)
01/2016 - 10/2008
3Prostatic Neoplasms (Prostate Cancer)
06/2007 - 11/2004
2Carcinogenesis
04/2002 - 02/2002
1Fanconi Anemia (Fanconi's Anemia)
08/2013
1Neoplasm Metastasis (Metastasis)
03/2009
1Ascites
03/2009
1Ovarian Epithelial Carcinoma
01/2008
1Papilloma (Papillomatosis)
04/2002

Drug/Important Bio-Agent (IBA)

8DNA (Deoxyribonucleic Acid)IBA
03/2016 - 11/2004
5Messenger RNA (mRNA)IBA
03/2016 - 10/2008
4Diphtheria ToxinIBA
03/2015 - 11/2004
4Proteins (Proteins, Gene)FDA Link
08/2009 - 02/2002
4PolymersIBA
08/2009 - 11/2004
3GemcitabineFDA Link
04/2016 - 11/2012
3EnzymesIBA
04/2016 - 02/2002
3LuciferasesIBA
11/2010 - 09/2005
3poly(beta-amino ester)IBA
08/2009 - 06/2007
2RNA-Binding Proteins (RNA-Binding Protein)IBA
04/2016 - 02/2014
2Carboplatin (JM8)FDA LinkGeneric
04/2016 - 02/2014
2Carrier Proteins (Binding Protein)IBA
03/2016 - 09/2015
2MesothelinIBA
03/2015 - 10/2008
2Cisplatin (Platino)FDA LinkGeneric
02/2014 - 08/2009
2Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2014 - 11/2012
2Pharmaceutical PreparationsIBA
08/2013 - 11/2012
2A-Form DNA (A-DNA)IBA
10/2008 - 11/2004
2PolyaminesIBA
04/2002 - 02/2002
2anthraceneIBA
04/2002 - 02/2002
2CarcinogensIBA
04/2002 - 02/2002
1RibonucleoproteinsIBA
04/2016
1Deoxycytidine KinaseIBA
04/2016
1Dendrimers (Dendrons)IBA
03/2016
1MicroRNAs (MicroRNA)IBA
03/2016
1Folic Acid (Vitamin M)FDA LinkGeneric
03/2016
1TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA
01/2016
1Death Domain ReceptorsIBA
01/2016
1AntibodiesIBA
03/2015
1Poly(ADP-ribose) Polymerase InhibitorsIBA
02/2014
1Antineoplastic Agents (Antineoplastics)IBA
02/2014
1Phosphotransferases (Kinase)IBA
02/2014
1Mitomycin (Mitomycin-C)FDA LinkGeneric
02/2014
1UbiquitinIBA
08/2013
1Peptide Hydrolases (Proteases)FDA Link
08/2013
1Mitoxantrone (Novantrone)FDA LinkGeneric
08/2013
1Biological ProductsIBA
11/2012
1Fluorouracil (Carac)FDA LinkGeneric
11/2012
1folfirinoxIBA
11/2012
1Drug CombinationsIBA
11/2012
1Leucovorin (Folinic Acid)FDA Link
11/2012
1Irinotecan (Camptosar)FDA LinkGeneric
11/2012
1Paclitaxel (Taxol)FDA LinkGeneric
08/2009
1Claudin-3IBA
03/2009
1Small Interfering RNA (siRNA)IBA
03/2009
1Tight Junction ProteinsIBA
03/2009
1Coxsackie and Adenovirus Receptor-Like Membrane ProteinIBA
09/2005
1human KLK3 proteinIBA
09/2005
1Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA
04/2002
1chrysarobinIBA
04/2002
1PutrescineIBA
02/2002
1SpermidineIBA
02/2002
1SpermineIBA
02/2002

Therapy/Procedure

7Therapeutics
04/2016 - 09/2005
1Drug Therapy (Chemotherapy)
02/2014
1Complementary Therapies (Alternative Medicine)
11/2012
1Intraperitoneal Injections
03/2009